why choose us

First received: August 26, 2023

Clinical Trial: Use of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers

Study Status: Completed

Recruit Status: RECRUITING

Condition: Non-healing Wound

Study Type: INTERVENTIONAL


Official Title: A Prospective Pilot Study Evaluating Wound Closure With the Application of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers

Brief Summary: The purpose of this clinical evaluation is to collect and compare outcomes data from patients with UT 1A diabetic foot ulcers treated with 510K FDA cleared, commercially available self-assembling peptide, AC5®Advanced Wound System, as compared to an advanced standard of care.Patient outcomes will be compared at the end of the study.

Read more